These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10972914)

  • 21. Premedication with acetaminophen or diphenhydramine for transfusion with leucoreduced blood products in children.
    Sanders RP; Maddirala SD; Geiger TL; Pounds S; Sandlund JT; Ribeiro RC; Pui CH; Howard SC
    Br J Haematol; 2005 Sep; 130(5):781-7. PubMed ID: 16115137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective study of symptomatic bacteremia following platelet transfusion and of its management.
    Chiu EK; Yuen KY; Lie AK; Liang R; Lau YL; Lee AC; Kwong YL; Wong S; Ng MH; Chan TK
    Transfusion; 1994; 34(11):950-4. PubMed ID: 7974703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immediate transfusion reactions.
    Climent-Peris C; Vélez-Rosario R
    P R Health Sci J; 2001 Sep; 20(3):229-35. PubMed ID: 11776724
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rationalised premedication practice for blood product transfusions: A single-centre quality initiative.
    Grant AM; Wright FA; O'Brien TA
    J Paediatr Child Health; 2022 Feb; 58(2):267-273. PubMed ID: 34397131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of adverse reaction rates for PAS C versus plasma platelet units.
    Cohn CS; Stubbs J; Schwartz J; Francis R; Goss C; Cushing M; Shaz B; Mair D; Brantigan B; Heaton WA
    Transfusion; 2014 Aug; 54(8):1927-34. PubMed ID: 24735171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets.
    Heddle NM; Klama L; Meyer R; Walker I; Boshkov L; Roberts R; Chambers S; Podlosky L; O'Hoski P; Levine M
    Transfusion; 1999 Mar; 39(3):231-8. PubMed ID: 10204584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet washing to prevent recurrent febrile reactions to leucocyte-reduced transfusions.
    Vo TD; Cowles J; Heal JM; Blumberg N
    Transfus Med; 2001 Feb; 11(1):45-7. PubMed ID: 11328571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The utility of < or =3-day-old whole-blood platelets in reducing the incidence of febrile nonhemolytic transfusion reactions.
    Kelley DL; Mangini J; Lopez-Plaza I; Triulzi DJ
    Transfusion; 2000 Apr; 40(4):439-42. PubMed ID: 10773056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions.
    Uhlmann EJ; Isgriggs E; Wallhermfechtel M; Goodnough LT
    Transfusion; 2001 Aug; 41(8):997-1000. PubMed ID: 11493730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelets expressing P-selectin and platelet-derived microparticles in stored platelet concentrates bind to PSGL-1 on filtrated leukocytes.
    Nomura S; Okamae F; Abe M; Hosokawa M; Yamaoka M; Ohtani T; Onishi S; Matsuzaki T; Teraoka A; Ishida T; Fukuhara S
    Clin Appl Thromb Hemost; 2000 Oct; 6(4):213-21. PubMed ID: 11030527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reactions to platelet transfusion: the effect of the storage time of the concentrate.
    Muylle L; Wouters E; De Bock R; Peetermans ME
    Transfus Med; 1992 Dec; 2(4):289-93. PubMed ID: 1339583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduction in adverse reactions to platelets by the removal of plasma supernatant and resuspension in a new additive solution (M-sol).
    Azuma H; Hirayama J; Akino M; Miura R; Kiyama Y; Imai K; Kasai M; Koizumi K; Kakinoki Y; Makiguchi Y; Kubo K; Atsuta Y; Fujihara M; Homma C; Yamamoto S; Kato T; Ikeda H
    Transfusion; 2009 Feb; 49(2):214-8. PubMed ID: 18798806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors influencing moderate to severe reactions to PLT transfusions: experience of the TRAP multicenter clinical trial.
    Enright H; Davis K; Gernsheimer T; McCullough JJ; Woodson R; Slichter SJ
    Transfusion; 2003 Nov; 43(11):1545-52. PubMed ID: 14617313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trend towards reduction of transfusion reactions using prestorage leukocyte-reduced and pooled whole blood-derived platelets and cost savings compared with poststorage whole blood-derived random platelets as evidenced by real-time hemovigilance.
    Park N; Correa Medina M; Martinez F; Throssel M; Dasgupta A; Knopfelmacher A; Villamin C; Rivas S; Tomczak N; Garg S; Layton L; Klein K
    Lab Med; 2024 May; 55(3):251-254. PubMed ID: 38175635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment.
    Osselaer JC; Cazenave JP; Lambermont M; Garraud O; Hidajat M; Barbolla L; Tardivel R; Defoin L; Waller C; Mendel I; Raidot JP; Kandel G; De Meuter R; Fabrigli P; Dehenau D; Arroyo JL; Padrón F; Gouezec H; Corral M; Jacquet M; Sundin D; Lin L; Corash L
    Vox Sang; 2008 May; 94(4):315-23. PubMed ID: 18248574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Premedication for the prevention of nonhemolytic transfusion reactions: a systematic review and meta-analysis.
    Ning S; Solh Z; Arnold DM; Morin PA
    Transfusion; 2019 Dec; 59(12):3609-3616. PubMed ID: 31670424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective randomized study of three types of platelet concentrates in patients with haematological malignancy: corrected platelet count increments and frequency of nonhaemolytic febrile transfusion reactions.
    Anderson NA; Gray S; Copplestone JA; Chan DC; Hamon M; Prentice AG; Johnson SA; Phillips M; van Waeg G; Oakhill A; Abeyasekera S; Pamphilon DH
    Transfus Med; 1997 Mar; 7(1):33-9. PubMed ID: 9089983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Universal leukodepletion of blood components results in a significant reduction of febrile non-hemolytic but not allergic transfusion reactions.
    Pruss A; Kalus U; Radtke H; Koscielny J; Baumann-Baretti B; Balzer D; Dörner T; Salama A; Kiesewetter H
    Transfus Apher Sci; 2004 Feb; 30(1):41-6. PubMed ID: 14746820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ABO-mismatched transfusions are not over-represented in febrile non-haemolytic transfusion reactions to platelets.
    Yazer MH; Raval JS; Triulzi DJ; Blumberg N
    Vox Sang; 2012 Feb; 102(2):175-7. PubMed ID: 21781126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical evaluation of transfusion of prestorage-leukoreduced apheresis platelets.
    Ogawa Y; Wakana M; Tanaka K; Oka K; Aso H; Hayashi M; Seno T; Ishida T; Nomura S; Fukuhara S
    Vox Sang; 1998; 75(2):103-9. PubMed ID: 9784662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.